<DOC>
	<DOCNO>NCT00938847</DOCNO>
	<brief_summary>Evaluative pilot study safety feasibility administration autologous bone bone marrow derive mononuclear cell endoventricular catheter normal border zone fo ischemic lesion .</brief_summary>
	<brief_title>Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration</brief_title>
	<detailed_description />
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>LVEF &lt; 40 % PCI late 6 hour infarction BMI &gt; 20 kg/m² &lt; 30 kg/m² PCI elder 14 day relevant valvular disease leave ventricular dysfunction cause reason ischemic cardiomyopathy history stroke , chronic atrial fibrillation , multivessel disease , thromboembolic event schedule CABG DM Type 1 &amp; extensive hypercholesterinemia pacemaker systemic disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>leave ventricular dysfunction</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>leave ventricular dysfunction ( LVDF ) acute myocardial infarction</keyword>
</DOC>